Geron (GERN) Change in Cash (2010 - 2026)
Geron's (GERN) quarterly Change in Cash came in at -$8.7 million in Q1 2026, down 282.95% year-on-year from $4.7 million in Q1 2025, and down 1466.18% quarter-over-quarter from -$553000.0 in Q4 2025.
Geron (GERN) Change in Cash (2010 - 2026) Analysis & Trends
Geron has disclosed Change in Cash across 17 years of filings, most recently posting -$8.7 million for Q1 2026.
- Change in Cash for Q1 2026 came in at -$8.7 million, down 282.95% year-over-year; the trailing twelve-month figure through Mar 2026 was -$14.8 million (up 85.91% YoY), and the FY2025 annual result was -$1.4 million, down 114.75% from the prior year.
- Change in Cash came in at -$8.7 million for Q1 2026 at Geron, down from -$553000.0 in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $119.7 million in Q1 2024 to a low of -$72.8 million in Q2 2024.
- The 5-year median for Change in Cash is -$3.5 million (2022), against an average of $2.1 million.
- Across the five-year window, Change in Cash surged 1677.35% in 2023 and plunged 282.95% in 2026, its largest moves.
- Geron's Change in Cash stood at -$4.3 million in 2022, then soared by 1036.9% to $39.9 million in 2023, then slumped by 53.18% to $18.7 million in 2024, then slumped by 102.96% to -$553000.0 in 2025, then plunged by 1466.18% to -$8.7 million in 2026.
- The last three Change in Cash figures came in at -$8.7 million (Q1 2026), -$553000.0 (Q4 2025), and $389000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -45.97 Mn |
| 10 | Geron | 729,618.77 | 729,618.77 | - | -8.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.66 Mn |
| Dec 31, 2025 | -553,000.00 |
| Sep 30, 2025 | 389,000.00 |
| Jun 30, 2025 | -6.01 Mn |
| Mar 31, 2025 | 4.73 Mn |
| Dec 31, 2024 | 18.68 Mn |
| Sep 30, 2024 | -55.87 Mn |
| Jun 30, 2024 | -72.81 Mn |
| Mar 31, 2024 | 119.74 Mn |
| Dec 31, 2023 | 39.89 Mn |
| Sep 30, 2023 | -26.19 Mn |
| Jun 30, 2023 | -55.70 Mn |
| Mar 31, 2023 | 55.93 Mn |
| Dec 31, 2022 | -4.26 Mn |
| Sep 30, 2022 | -14.95 Mn |
| Jun 30, 2022 | 44.73 Mn |
| Mar 31, 2022 | -3.55 Mn |
| Dec 31, 2021 | 5.84 Mn |
| Sep 30, 2021 | -28.25 Mn |
| Jun 30, 2021 | 25.75 Mn |